Analysis of the correlations of mucins, inflammatory markers, and clinical tests in dry eye

Cornea

Volumn 32, Issue 7, 2013, Pages 928-932

  Zhang, Jianan ^a   Yan, Xiaoming ^a   Li, Haili ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Dry eye; IL 6; Inflammatory factor; MUC5AC; Mucin

Indexed keywords

INTERLEUKIN 6; MUCIN; MUCIN 5AC; PROMETHAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRY EYE; EYE EXAMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPRESSION CYTOLOGY; MAJOR CLINICAL STUDY; MALE; OCULAR SURFACE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCHIRMER TEST; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CONJUNCTIVA; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; EPITHELIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; MALE; MIDDLE AGED; MUCIN 5AC; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84879106136     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182801622     Document Type: Article

References (30)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work-Shop (2007). Ocul Surf. 2007;5:75-92.
2. Pflugfelder S. C. Anti-inflammatory therapy of dry eye. Ocul Surf. 2003; 1:31-36.
3. Gao J, Morgan G, Tieu D, et al. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRLP/lpr mice. Exp Eye Res. 2004;78:823-835.
4. Strong B, Farley W, Stern M. E, et al. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 2005;24:80-85.
5. Manganelli P, Fietta P. Apoptosis and Sjögren syndrome. Semin Arthritis Rheum. 2003;33:49-65.
6. De Paiva C. S, Pflugfelder S. C. Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol. 2004;137:109-115.
7. Gipson I. K, Spurr-Michaud S. J, Senchyna M, et al. Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye. Cornea. 2011;30:1346-1352.
8. Wickham L. A, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2000;78:146-153.
9. Oprea L, Tiberghien A, Creuzot-Garcher C, et al. Hormonal regulatory influence in tear film [in French]. J Fr Ophtalmol. 2004;27:933-941.
10. Argüeso P, Balaram M, Spurr-Michaud S, et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci. 2002;43:1004-1011.
11. Zhu L, Shen J, Zhang C, et al. Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model. Mol Vis. 2009;15:250-258.
12. Pisella P. J, Brignole F, Debbasch C, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology. 2000;107:1841-1849.
13. Massingale M. L, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28: 1023-1027.
14. Yoon K. C, Jeong I. Y, Park Y. G, et al. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26:431-437.
15. Adatia F. A, Michaeli-Cohen A, Naor J, et al. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögrens's syndrome. Can J Ophthalmol. 2004;39:767-771.
16. Nichols K. K, Nichols J. J, Mitchell G. L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-770.
17. Ozcura F, Aydin S, Helvaci M. R. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm. 2007;15: 389-393.
18. Zhang M, Chen J. Q, Liu Z. G, et al. Clinical characteristics of patients with dry eye syndrome [in Chinese]. Zhonghua Yan Ke Za Zhi. 2003;39: 5-9.
19. Singh R, Joseph A, Umapathy T, et al. Impression cytology of the ocular surface. Br J Ophthalmol. 2005;89:1655-1659.
20. Davidson H. J, Kuonen V. J. The tear film and ocular mucins. Vet Ophthalmol. 2004;7:71-77.
21. Carraway KL, Price-Schiavi SA, Komatsu M, et al. Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). Front Biosci. 2000;5:D95-D107.
22. Brignole F, Pisella P. J, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356-1363.
23. Pflugfelder S. C, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
24. Pflugfelder S. C. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337-342.
25. Pflugfelder S. C, de Paiva C. S, Li D. Q, et al. Epithelial-immune cell interaction in dry eye. Cornea. 2008;27(suppl 1):S9-S11.
26. Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45(suppl 2) :S211-S220.
27. Gamache D. A, Dimitrijevich S. D, Weimer L. K, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm. 1997;5:117-128.
28. Johnson M. E, Murphy P. J. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res. 2004;23:449-474.
29. Lekhanont K, Park C. Y, Smith J. A, et al. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. J Ocul Pharmacol Ther. 2007;23:27-34.
30. Cordero-Coma M, Anzaar F, Sobrin L, et al. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm. 2007;15:99-104.